Students from historically Black colleges and universities (HBCUs) joined Columbia biomedical research laboratories for a summer of science, as part of CUIMC’s newest summer program
The goal of the ADRC HS Scholars Program is to reach talented young people from backgrounds underrepresented in science and medicine, and to encourage and inspire them toward careers in these fields.
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz
A new study finds that signs of covert consciousness--subtle brainwaves detectable with EEG--are the strongest predictor of eventual recovery for brain-injured patients
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
Dr. Olajide Williams, Professor of Neurology and Associate Dean of Community Research and Engagement, was honored as a "Rising Leader" for his significant contributions in advancing health equity.